Viking Thera
(VKTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,531 | -68,867 | -49,308 | -33,535 | -16,103 |
| Depreciation Amortization | -289 | 1,567 | 1,540 | 1,228 | 759 |
| Accounts payable and accrued liabilities | -4,732 | 7,085 | 1,698 | 4,661 | 1,707 |
| Other Working Capital | -8,404 | 10,189 | 3,709 | 3,712 | 2,453 |
| Other Operating Activity | 8,313 | 1,629 | 4,890 | -38 | 654 |
| Operating Cash Flow | $-24,643 | $-48,397 | $-37,471 | $-23,972 | $-10,530 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,198 | 54,753 | 47,493 | 20,599 | 1,619 |
| Investing Cash Flow | $2,198 | $54,753 | $47,493 | $20,599 | $1,619 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,966 | 848 | 698 | 698 | 614 |
| Common Stock Repurchased | N/A | -6,795 | -6,795 | -6,795 | -5,121 |
| Other Financing Activity | 218 | 10,110 | -489 | -499 | -499 |
| Financing Cash Flow | $4,184 | $4,163 | $-6,586 | $-6,596 | $-5,006 |
| Exchange Rate Effect | -9 | -258 | -399 | -176 | N/A |
| Beginning Cash Position | 36,632 | 26,371 | 26,371 | 26,371 | 26,371 |
| End Cash Position | 18,362 | 36,632 | 29,408 | 16,226 | 12,454 |
| Net Cash Flow | $-18,261 | $10,261 | $3,037 | $-10,145 | $-13,917 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,643 | -48,397 | -37,471 | -23,972 | -10,530 |
| Free Cash Flow | -24,643 | -48,397 | -37,471 | -23,972 | -10,530 |